• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体抑制疟疾传播阻断疫苗抗原 Pfs25 的多个作用点的分子定义。

Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.

机构信息

Program in Molecular Medicine, The Hospital for Sick Children Research Institute, 686 Bay St, Toronto, ON, Canada, M5G 0A4.

Department of Biochemistry, University of Toronto, 1 King's College Circle, Toronto, ON, Canada, M5S 1A8.

出版信息

Nat Commun. 2017 Nov 16;8(1):1568. doi: 10.1038/s41467-017-01924-3.

DOI:10.1038/s41467-017-01924-3
PMID:29146922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5691035/
Abstract

The Plasmodium falciparum Pfs25 protein (Pfs25) is a leading malaria transmission-blocking vaccine antigen. Pfs25 vaccination is intended to elicit antibodies that inhibit parasite development when ingested by Anopheles mosquitoes during blood meals. The Pfs25 three-dimensional structure has remained elusive, hampering a molecular understanding of its function and limiting immunogen design. We report six crystal structures of Pfs25 in complex with antibodies elicited by immunization via Pfs25 virus-like particles in human immunoglobulin loci transgenic mice. Our structural findings reveal the fine specificities associated with two distinct immunogenic sites on Pfs25. Importantly, one of these sites broadly overlaps with the epitope of the well-known 4B7 mouse antibody, which can be targeted simultaneously by antibodies that target a non-overlapping site to additively increase parasite inhibition. Our molecular characterization of inhibitory antibodies informs on the natural disposition of Pfs25 on the surface of ookinetes and provides the structural blueprints to design next-generation immunogens.

摘要

疟原虫恶性疟原虫蛋白 25(Pfs25)是一种主要的疟疾传播阻断疫苗抗原。Pfs25 疫苗接种旨在诱导抗体,当疟原虫在蚊血餐中被按蚊摄入时,抑制寄生虫的发育。Pfs25 的三维结构仍然难以捉摸,这阻碍了对其功能的分子理解,并限制了免疫原的设计。我们报告了通过在人类免疫球蛋白基因座转基因小鼠中用 Pfs25 病毒样颗粒免疫接种来诱导的抗体与 Pfs25 复合物的六个晶体结构。我们的结构研究结果揭示了与 Pfs25 上两个不同免疫原性位点相关的精细特异性。重要的是,其中一个位点与著名的 4B7 小鼠抗体的表位广泛重叠,该抗体可以被靶向非重叠位点的抗体同时靶向,从而相加增加寄生虫抑制。我们对抑制性抗体的分子特征分析阐明了 Pfs25 在卵囊体表面的自然分布,并为设计下一代免疫原提供了结构蓝图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/c5ca31ce8e9a/41467_2017_1924_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/0400a65c7898/41467_2017_1924_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/cf6bf62fbf8d/41467_2017_1924_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/cd351ced9ebb/41467_2017_1924_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/92f90cda9737/41467_2017_1924_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/a52320e8c32d/41467_2017_1924_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/dae8230ca7f2/41467_2017_1924_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/c5ca31ce8e9a/41467_2017_1924_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/0400a65c7898/41467_2017_1924_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/cf6bf62fbf8d/41467_2017_1924_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/cd351ced9ebb/41467_2017_1924_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/92f90cda9737/41467_2017_1924_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/a52320e8c32d/41467_2017_1924_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/dae8230ca7f2/41467_2017_1924_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2db/5691035/c5ca31ce8e9a/41467_2017_1924_Fig7_HTML.jpg

相似文献

1
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.抗体抑制疟疾传播阻断疫苗抗原 Pfs25 的多个作用点的分子定义。
Nat Commun. 2017 Nov 16;8(1):1568. doi: 10.1038/s41467-017-01924-3.
2
Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.用一种疟疾传播阻断候选疫苗Pfs25进行鼻腔免疫,可在小鼠中诱导出针对恶性疟原虫野外分离株的完全保护性免疫。
Infect Immun. 2005 Nov;73(11):7375-80. doi: 10.1128/IAI.73.11.7375-7380.2005.
3
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission.靶向Pfs25的新型腺病毒疫苗载体可引发抑制恶性疟原虫传播的抗体。
Malar J. 2017 Jun 15;16(1):254. doi: 10.1186/s12936-017-1896-7.
4
Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.使用表达靶抗原Pfs25的转基因伯氏疟原虫寄生虫评估恶性疟原虫传播阻断疫苗的小鼠模型。
Infect Immun. 2008 May;76(5):2018-24. doi: 10.1128/IAI.01409-07. Epub 2008 Mar 3.
5
Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25.人类接种 Pfs25 可引发针对疟疾传播的强效抗体谱系
Nat Commun. 2019 Sep 24;10(1):4328. doi: 10.1038/s41467-019-11980-6.
6
Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.通过DNA和蛋白质免疫联合诱导食蟹猴产生恶性疟原虫传播阻断抗体。
Infect Immun. 2004 Jan;72(1):253-9. doi: 10.1128/IAI.72.1.253-259.2004.
7
Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding.经成功的蛋白质复性后,在大肠杆菌中表达的恶性疟原虫 Pfs25 引起的强效疟疾传播阻断抗体反应。
Infect Immun. 2014 Apr;82(4):1453-9. doi: 10.1128/IAI.01438-13. Epub 2014 Jan 13.
8
Poor CD4 T Cell Immunogenicity Limits Humoral Immunity to Transmission-Blocking Candidate Pfs25 in Humans.CD4 T 细胞免疫原性差限制了对人类传播阻断候选 Pfs25 的体液免疫。
Front Immunol. 2021 Sep 30;12:732667. doi: 10.3389/fimmu.2021.732667. eCollection 2021.
9
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.疟疾候选疫苗Pfs25/Pvs25诱导的传播阻断活性是抗体滴度的直接且可预测的函数。
Malar J. 2007 Aug 8;6:107. doi: 10.1186/1475-2875-6-107.
10
Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.疟疾来源的糖基磷脂酰肌醇锚增强了可阻断疟疾传播的抗Pfs25功能性抗体。
Biochemistry. 2018 Feb 6;57(5):516-519. doi: 10.1021/acs.biochem.7b01099. Epub 2018 Jan 16.

引用本文的文献

1
Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.针对疟疾传播的瓶颈:抗体-表位描述指导下一代生物医学干预措施的设计。
Immunol Rev. 2025 Mar;330(1):e70001. doi: 10.1111/imr.70001.
2
Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein.保护性抗体靶向因疟原虫子孢子蛋白裂解而暴露的隐蔽表位。
Science. 2025 Jan 3;387(6729):eadr0510. doi: 10.1126/science.adr0510.
3
Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria.

本文引用的文献

1
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission.靶向Pfs25的新型腺病毒疫苗载体可引发抑制恶性疟原虫传播的抗体。
Malar J. 2017 Jun 15;16(1):254. doi: 10.1186/s12936-017-1896-7.
2
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.Pfs25-EPA/Alhydrogel®(一种针对恶性疟原虫的传播阻断疫苗)的安全性和免疫原性:一项针对未感染疟疾成年人的开放标签研究。
PLoS One. 2016 Oct 17;11(10):e0163144. doi: 10.1371/journal.pone.0163144. eCollection 2016.
3
多阶段保护型抗 CelTOS 单克隆抗体,对疟疾具有跨物种的无菌保护作用。
Nat Commun. 2024 Aug 29;15(1):7487. doi: 10.1038/s41467-024-51701-2.
4
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5.天然疟疾感染会引发针对血期抗原 RH5 的罕见但强效的中和抗体。
Cell. 2024 Sep 5;187(18):4981-4995.e14. doi: 10.1016/j.cell.2024.06.037. Epub 2024 Jul 25.
5
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.分析疟疾蛋白 RH5 的多样化抗原表位,鉴定出一种有效的疫苗诱导的人类公共抗体克隆型。
Cell. 2024 Sep 5;187(18):4964-4980.e21. doi: 10.1016/j.cell.2024.06.015. Epub 2024 Jul 25.
6
Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum.多样性和选择分析将阻断传播的抗原确定为恶性疟原虫的最佳疫苗候选物。
EBioMedicine. 2024 Aug;106:105227. doi: 10.1016/j.ebiom.2024.105227. Epub 2024 Jul 16.
7
Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in .多样性和选择分析确定传播阻断抗原是……中最佳的疫苗候选物。
medRxiv. 2024 May 12:2024.05.11.24307175. doi: 10.1101/2024.05.11.24307175.
8
Recent advances in immunotherapies against infectious diseases.针对传染病的免疫疗法的最新进展。
Immunother Adv. 2020 Nov 25;1(1):ltaa007. doi: 10.1093/immadv/ltaa007. eCollection 2021 Jan.
9
Development of an anti-Pfs230 monoclonal antibody as a Plasmodium falciparum gametocyte blocker.开发一种抗Pfs230单克隆抗体作为恶性疟原虫配子体阻断剂。
Res Sq. 2023 Dec 19:rs.3.rs-3757253. doi: 10.21203/rs.3.rs-3757253/v1.
10
A human antibody epitope map of the malaria vaccine antigen Pfs25.疟疾疫苗抗原Pfs25的人源抗体表位图谱。
NPJ Vaccines. 2023 Aug 4;8(1):108. doi: 10.1038/s41541-023-00712-z.
An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines.
用于评估疟疾传播阻断疫苗的标准膜饲法的实验室间比较。
Malar J. 2016 Sep 9;15(1):463. doi: 10.1186/s12936-016-1515-z.
4
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.定制免疫原引导亲和力成熟以产生HIV中和抗体。
Cell. 2016 Sep 8;166(6):1459-1470.e11. doi: 10.1016/j.cell.2016.08.005.
5
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice.在人免疫球蛋白基因座转基因小鼠中启动HIV-1广泛中和抗体前体。
Science. 2016 Sep 30;353(6307):1557-1560. doi: 10.1126/science.aah3945. Epub 2016 Sep 8.
6
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.评估从多个可溶性表达平台表达的Pfs25作为传播阻断疫苗候选物的情况。
Malar J. 2016 Aug 11;15(1):405. doi: 10.1186/s12936-016-1464-6.
7
Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay.在恶性疟原虫标准膜饲实验中,传播阻断活性由传播减少活性和对照卵囊数量共同决定。
Vaccine. 2016 Jul 29;34(35):4145-4151. doi: 10.1016/j.vaccine.2016.06.066. Epub 2016 Jun 29.
8
Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles.展示具有自组装纳米颗粒的类天然三聚体 HIV-1 抗原。
Nat Commun. 2016 Jun 28;7:12041. doi: 10.1038/ncomms12041.
9
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.通过将Pfs25与IMX313多聚化技术融合来增强疟疾疫苗的免疫原性和传播阻断活性。
Sci Rep. 2016 Jan 8;6:18848. doi: 10.1038/srep18848.
10
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes.非中和表位暴露减少的稳定化HIV-1包膜三聚体的免疫原性
Cell. 2015 Dec 17;163(7):1702-15. doi: 10.1016/j.cell.2015.11.056.